Overexpression of G6PD Represents a Potential Prognostic Factor in Clear Cell Renal Cell Carcinoma


Glucose-6-phosphate dehydrogenase (G6PD) participates in glucose metabolism and it acts as the rate-limiting enzyme of the pentose phosphate pathway (PPP). Recently, G6PD dysregulation has been found in a variety of human cancers. Through analyzing published data in The Cancer Genome Atlas (TCGA), our pilot study indicated that G6PD mRNA expression was… (More)
DOI: 10.7150/jca.16858


8 Figures and Tables